Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy

ConclusionA clearer understanding of the variable history of DCIS coupled with advances in genomic profiling of the disease holds the promise of reducing widespread over-treatment of this non-invasive cancer. Additionally, identification of higher risk of recurrence subsets may select patients for whom more aggressive treatment may be appropriate.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research